Clinical Trials Directory

Trials / Conditions / Ciliary Body and Choroid Melanoma, Medium/Large Size

Ciliary Body and Choroid Melanoma, Medium/Large Size

11 registered clinical trials studyying Ciliary Body and Choroid Melanoma, Medium/Large Size.

StatusTrialSponsorPhase
Active Not RecruitingSunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
NCT02068586
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 2
TerminatedRadioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases
NCT01730157
Case Comprehensive Cancer CenterEARLY_Phase 1
CompletedCixutumumab in Treating Patients With Metastatic Melanoma of the Eye
NCT01413191
National Cancer Institute (NCI)Phase 2
CompletedSorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye
NCT00329641
National Cancer Institute (NCI)Phase 2
CompletedDacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic I
NCT01100528
Case Comprehensive Cancer CenterPhase 2
CompletedVEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
NCT00450255
National Cancer Institute (NCI)Phase 2
CompletedAZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
NCT00243061
National Cancer Institute (NCI)Phase 2
CompletedBortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma
NCT00288041
National Cancer Institute (NCI)Phase 2
CompletedVorinostat in Treating Patients With Metastatic or Unresectable Melanoma
NCT00121225
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma
NCT00089063
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy in Treating Patients With Stage IIC-IV Melanoma
NCT00085189
University of Southern CaliforniaPhase 2